{"id":59613,"date":"2026-01-18T18:19:07","date_gmt":"2026-01-18T18:19:07","guid":{"rendered":"https:\/\/ibima.eu\/?page_id=59613"},"modified":"2026-01-19T07:29:34","modified_gmt":"2026-01-19T07:29:34","slug":"brain-health-partnership","status":"publish","type":"page","link":"https:\/\/ibima.eu\/en\/brain-health-partnership\/","title":{"rendered":"Brain Health PARTNERSHIP"},"content":{"rendered":"<p>[et_pb_section fb_built=\u00bb1&#8243; admin_label=\u00bbsection\u00bb _builder_version=\u00bb4.25.1&#8243; custom_padding=\u00bb||0px|||\u00bb locked=\u00bboff\u00bb collapsed=\u00bboff\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_row column_structure=\u00bb1_5,3_5,1_5&#8243; _builder_version=\u00bb4.27.4&#8243; _module_preset=\u00bbdefault\u00bb custom_margin=\u00bb21px||||false|false\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_column type=\u00bb1_5&#8243; _builder_version=\u00bb4.25.1&#8243; _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][\/et_pb_column][et_pb_column type=\u00bb3_5&#8243; _builder_version=\u00bb4.25.1&#8243; _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_image src=\u00bbhttps:\/\/ibima.eu\/wp-content\/uploads\/2026\/01\/Breain-Health-logo.jpg\u00bb title_text=\u00bbBreain Health logo\u00bb align=\u00bbcenter\u00bb _builder_version=\u00bb4.27.4&#8243; _module_preset=\u00bbdefault\u00bb width=\u00bb54%\u00bb module_alignment=\u00bbcenter\u00bb custom_margin=\u00bb26px||||false|false\u00bb global_colors_info=\u00bb{}\u00bb][\/et_pb_image][\/et_pb_column][et_pb_column type=\u00bb1_5&#8243; _builder_version=\u00bb4.25.1&#8243; _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=\u00bb4.27.4&#8243; _module_preset=\u00bbdefault\u00bb custom_margin=\u00bb59px||||false|false\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_column type=\u00bb4_4&#8243; _builder_version=\u00bb4.25.1&#8243; _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_heading title=\u00bbBrainHealth \u2013 Calls for Transnational Proposals 2026&#8243; _builder_version=\u00bb4.27.4&#8243; _module_preset=\u00bbdefault\u00bb title_text_align=\u00bbcenter\u00bb title_text_color=\u00bb#0C71C3&#8243; title_line_height=\u00bb1.3em\u00bb module_alignment=\u00bbcenter\u00bb hover_enabled=\u00bb0&#8243; global_colors_info=\u00bb{}\u00bb sticky_enabled=\u00bb0&#8243;][\/et_pb_heading][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=\u00bb4.27.4&#8243; _module_preset=\u00bbdefault\u00bb width=\u00bb75.9%\u00bb custom_margin=\u00bb20px|auto||159px|false|false\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_column type=\u00bb4_4&#8243; _builder_version=\u00bb4.25.1&#8243; _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_text admin_label=\u00bbText\u00bb _builder_version=\u00bb4.27.4&#8243; header_text_color=\u00bb#000000&#8243; background_size=\u00bbinitial\u00bb background_position=\u00bbtop_left\u00bb background_repeat=\u00bbrepeat\u00bb width=\u00bb100%\u00bb custom_margin=\u00bb1px|-78px|||false|false\u00bb hover_enabled=\u00bb0&#8243; global_colors_info=\u00bb{}\u00bb sticky_enabled=\u00bb0&#8243;]<\/p>\n<p data-start=\"323\" data-end=\"601\">El partneriado BrainHealth Partnership ha lanzado dos convocatorias en el a\u00f1o soso6, siendo estas:<\/p>\n<ol>\n<li data-start=\"323\" data-end=\"601\">JTC2026 Call 1: Neurological Mental and Sensory Disorders<\/li>\n<li data-start=\"323\" data-end=\"601\">JTC2026 Call 2: Neurodegenerative Disorders<\/li>\n<\/ol>\n<p>[\/et_pb_text][et_pb_heading title=\u00bbJTC2026 Call 1: Neurological, Mental and Sensory Disorders\u00bb _builder_version=\u00bb4.27.4&#8243; _module_preset=\u00bbdefault\u00bb title_font=\u00bb|||on|||||\u00bb title_text_color=\u00bb#0C71C3&#8243; min_height=\u00bb0px\u00bb custom_margin=\u00bb20px||||false|false\u00bb hover_enabled=\u00bb0&#8243; global_colors_info=\u00bb{}\u00bb custom_padding__hover_enabled=\u00bbon|desktop\u00bb sticky_enabled=\u00bb0&#8243;][\/et_pb_heading][\/et_pb_column][\/et_pb_row][et_pb_row admin_label=\u00bbrow\u00bb _builder_version=\u00bb4.25.1&#8243; background_size=\u00bbinitial\u00bb background_position=\u00bbtop_left\u00bb background_repeat=\u00bbrepeat\u00bb width=\u00bb77.1%\u00bb custom_margin=\u00bb|-259px||161px||\u00bb custom_padding=\u00bb|0px||9px||\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_column type=\u00bb4_4&#8243; _builder_version=\u00bb4.16&#8243; custom_padding=\u00bb|||\u00bb global_colors_info=\u00bb{}\u00bb custom_padding__hover=\u00bb|||\u00bb][et_pb_text admin_label=\u00bbText\u00bb _builder_version=\u00bb4.27.4&#8243; header_text_color=\u00bb#000000&#8243; background_size=\u00bbinitial\u00bb background_position=\u00bbtop_left\u00bb background_repeat=\u00bbrepeat\u00bb width=\u00bb100%\u00bb custom_margin=\u00bb11px|-78px|||false|false\u00bb global_colors_info=\u00bb{}\u00bb]<\/p>\n<p data-start=\"278\" data-end=\"709\">La convocatoria JTC2026 Call 1 de BrainHealth se centra en los factores biol\u00f3gicos, sociales y ambientales que influyen en la salud cerebral a lo largo de la vida, en el \u00e1mbito de los trastornos neurol\u00f3gicos, mentales y sensoriales. El objetivo es promover investigaciones multinacionales, colaborativas e interdisciplinarias que aborden preguntas cr\u00edticas de car\u00e1cter translacional sobre la trayectoria de la salud cerebral.<\/p>\n<p data-start=\"711\" data-end=\"977\">Los proyectos deber\u00e1n explorar c\u00f3mo los factores biol\u00f3gicos, sociales y ambientales afectan la aparici\u00f3n, progresi\u00f3n y manejo de estos trastornos, desde etapas prenatales hasta la edad avanzada. Las propuestas deben incluir al menos dos de los siguientes aspectos:<\/p>\n<ul data-start=\"978\" data-end=\"1230\">\n<li data-start=\"978\" data-end=\"1033\">\n<p data-start=\"980\" data-end=\"1033\">Mecanismos de acci\u00f3n de los factores identificados.<\/p>\n<\/li>\n<li data-start=\"1034\" data-end=\"1116\">\n<p data-start=\"1036\" data-end=\"1116\">Reconocimiento temprano, diagn\u00f3stico y pron\u00f3stico asociados a dichos factores.<\/p>\n<\/li>\n<li data-start=\"1117\" data-end=\"1230\">\n<p data-start=\"1119\" data-end=\"1230\">Prevenci\u00f3n, tratamientos, intervenciones, desarrollo tecnol\u00f3gico, atenci\u00f3n y apoyo vinculados a los factores.<\/p>\n<\/li>\n<\/ul>\n<p data-start=\"53\" data-end=\"139\">Adem\u00e1s, los siguientes aspectos son importantes en el contexto de esta convocatoria:<\/p>\n<ul data-start=\"141\" data-end=\"802\">\n<li data-start=\"141\" data-end=\"262\">\n<p data-start=\"143\" data-end=\"262\">Las solicitudes deben investigar c\u00f3mo los factores afectan la trayectoria de la salud cerebral a lo largo de la vida.<\/p>\n<\/li>\n<li data-start=\"263\" data-end=\"436\">\n<p data-start=\"265\" data-end=\"436\">Los resultados que beneficien la calidad de vida de los pacientes y sus cuidadores son de especial importancia y deben ser definidos y especificados de manera expl\u00edcita.<\/p>\n<\/li>\n<li data-start=\"437\" data-end=\"570\">\n<p data-start=\"439\" data-end=\"570\">Se fomentan las propuestas que aborden aspectos relacionados con discapacidad, g\u00e9nero, \u00e9tica, cultura y factores socioecon\u00f3micos.<\/p>\n<\/li>\n<li data-start=\"571\" data-end=\"802\">\n<p data-start=\"573\" data-end=\"802\">Se valorar\u00e1n especialmente los enfoques que integren datos multimodales, el uso de tecnolog\u00edas port\u00e1tiles accesibles (por ejemplo, dispositivos m\u00f3viles), inteligencia artificial\/gemelos digitales y la reutilizaci\u00f3n de f\u00e1rmacos.<\/p>\n<\/li>\n<\/ul>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=\u00bb4.27.4&#8243; _module_preset=\u00bbdefault\u00bb width=\u00bb75.9%\u00bb custom_margin=\u00bb10px|auto||159px|false|false\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_column type=\u00bb4_4&#8243; _builder_version=\u00bb4.25.1&#8243; _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_heading _builder_version=\u00bb4.27.4&#8243; _module_preset=\u00bbdefault\u00bb title_font=\u00bb|||on|||||\u00bb title_text_color=\u00bb#0C71C3&#8243; min_height=\u00bb0px\u00bb custom_margin=\u00bb1px||||false|false\u00bb hover_enabled=\u00bb0&#8243; global_colors_info=\u00bb{}\u00bb custom_padding__hover_enabled=\u00bbon|desktop\u00bb sticky_enabled=\u00bb0&#8243;][\/et_pb_heading][et_pb_text _builder_version=\u00bb4.27.4&#8243; _module_preset=\u00bbdefault\u00bb custom_padding=\u00bb||0px|11px||\u00bb global_colors_info=\u00bb{}\u00bb][\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=\u00bb4.27.4&#8243; _module_preset=\u00bbdefault\u00bb width=\u00bb75.9%\u00bb custom_margin=\u00bb14px|auto|-13px|159px|false|false\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_column type=\u00bb4_4&#8243; _builder_version=\u00bb4.25.1&#8243; _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_heading title=\u00bbCondiciones generales\u00bb _builder_version=\u00bb4.27.4&#8243; _module_preset=\u00bbdefault\u00bb title_font=\u00bb|||on|||||\u00bb title_text_color=\u00bb#0C71C3&#8243; min_height=\u00bb0px\u00bb custom_margin=\u00bb1px||||false|false\u00bb global_colors_info=\u00bb{}\u00bb custom_padding__hover_enabled=\u00bbon|desktop\u00bb][\/et_pb_heading][et_pb_text _builder_version=\u00bb4.27.4&#8243; _module_preset=\u00bbdefault\u00bb custom_padding=\u00bb||0px|11px||\u00bb global_colors_info=\u00bb{}\u00bb]<\/p>\n<ul>\n<li>Pa\u00edses participantes: Australia, B\u00e9lgica (Federaci\u00f3n Valona-Bruselas), B\u00e9lgica (Flandes), Croacia, Dinamarca, Estonia, Finlandia, Francia, Alemania, Grecia, Hungr\u00eda, Irlanda, Islandia, Israel, Italia, Italia (Regi\u00f3n de Lombard\u00eda), Letonia, Lituania, Malta, Pa\u00edses Bajos, Nueva Zelanda, Noruega, Polonia, Portugal, Rep\u00fablica de Moldavia, Ruman\u00eda, Eslovaquia, Espa\u00f1a, Suecia, Suiza, Taiw\u00e1n y Turqu\u00eda.<\/li>\n<li>Cada socio del proyecto ser\u00e1 financiado por su organismo nacional\/regional correspondiente.<\/li>\n<li>El consorcio m\u00ednimo elegible ser\u00e1 de socios elegibles de 3 pa\u00edses diferentes participantes en la convocatoria.<\/li>\n<li>El consorcio m\u00e1ximo ser\u00e1 de 6 socios financiables, con un m\u00e1ximo de 2 socios elegibles por pa\u00eds.\u00a0<\/li>\n<li>Si en el consorcio Croacia, Malta, Moldavia, Eslovaquia, Eslovenia, Turqu\u00eda.<\/li>\n<li>Se permiten colaboradores autofinanciados, que se contabilizar\u00e1n en el consorcio de la misma manera que los socios.<\/li>\n<li>Procedimiento en <strong data-start=\"2896\" data-end=\"2910\">dos fases:<\/strong> pre-propuestas y propuestas completas.<\/li>\n<\/ul>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=\u00bb4.27.4&#8243; _module_preset=\u00bbdefault\u00bb width=\u00bb75.9%\u00bb custom_margin=\u00bb14px|auto|-13px|159px|false|false\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_column type=\u00bb4_4&#8243; _builder_version=\u00bb4.25.1&#8243; _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_heading title=\u00bbFinanciaci\u00f3n\u00bb _builder_version=\u00bb4.27.4&#8243; _module_preset=\u00bbdefault\u00bb title_font=\u00bb|||on|||||\u00bb title_text_color=\u00bb#0C71C3&#8243; min_height=\u00bb0px\u00bb custom_margin=\u00bb1px||||false|false\u00bb global_colors_info=\u00bb{}\u00bb custom_padding__hover_enabled=\u00bbon|desktop\u00bb][\/et_pb_heading][et_pb_text _builder_version=\u00bb4.27.4&#8243; _module_preset=\u00bbdefault\u00bb custom_padding=\u00bb||0px|11px||\u00bb global_colors_info=\u00bb{}\u00bb]<\/p>\n<p><strong data-start=\"465\" data-end=\"531\" style=\"font-size: 14px;\">Las entidades espa\u00f1olas podr\u00e1n solicitar los fondos al Instituto de Salud Carlos III, con las siguientes reglas:<\/strong><\/p>\n<ul data-start=\"534\" data-end=\"944\">\n<li data-start=\"534\" data-end=\"758\">\n<p data-start=\"536\" data-end=\"559\">Como <strong data-start=\"541\" data-end=\"556\">coordinador<\/strong>:<\/p>\n<ul data-start=\"562\" data-end=\"758\">\n<li data-start=\"562\" data-end=\"639\">\n<p data-start=\"564\" data-end=\"639\"><strong data-start=\"564\" data-end=\"577\">275.000 \u20ac<\/strong>, si hay solo un socio espa\u00f1ol solicitando fondos al ISCIII.<\/p>\n<\/li>\n<li data-start=\"642\" data-end=\"758\">\n<p data-start=\"644\" data-end=\"758\"><strong data-start=\"644\" data-end=\"668\">300.000 \u20ac a repartir<\/strong>, si hay dos socios solicitando financiaci\u00f3n al ISCIII, siendo uno de ellos coordinador.<\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li data-start=\"759\" data-end=\"944\">\n<p data-start=\"761\" data-end=\"778\">Como <strong data-start=\"766\" data-end=\"775\">socio<\/strong>:<\/p>\n<ul data-start=\"781\" data-end=\"944\">\n<li data-start=\"781\" data-end=\"858\">\n<p data-start=\"783\" data-end=\"858\"><strong data-start=\"783\" data-end=\"796\">220.000 \u20ac<\/strong>, si hay solo un socio espa\u00f1ol solicitando fondos al ISCIII.<\/p>\n<\/li>\n<li data-start=\"861\" data-end=\"944\">\n<p data-start=\"863\" data-end=\"944\"><strong data-start=\"863\" data-end=\"887\">250.000 \u20ac a repartir<\/strong>, si hay dos socios solicitando financiaci\u00f3n al ISCIII.<\/p>\n<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=\u00bb4.27.4&#8243; _module_preset=\u00bbdefault\u00bb width=\u00bb75.9%\u00bb min_height=\u00bb317px\u00bb custom_margin=\u00bb10px|auto||159px|false|false\u00bb custom_padding=\u00bb||0px|||\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_column type=\u00bb4_4&#8243; _builder_version=\u00bb4.25.1&#8243; _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_heading title=\u00bbfechas clave\u00bb _builder_version=\u00bb4.27.4&#8243; _module_preset=\u00bbdefault\u00bb title_font=\u00bb|||on|||||\u00bb title_text_color=\u00bb#0C71C3&#8243; min_height=\u00bb0px\u00bb custom_margin=\u00bb1px||||false|false\u00bb global_colors_info=\u00bb{}\u00bb custom_padding__hover_enabled=\u00bbon|desktop\u00bb][\/et_pb_heading][et_pb_text _builder_version=\u00bb4.27.4&#8243; _module_preset=\u00bbdefault\u00bb custom_margin=\u00bb||8px|||\u00bb custom_padding=\u00bb||0px|11px||\u00bb global_colors_info=\u00bb{}\u00bb]<\/p>\n<ul>\n<li>8 de diciembre de 2025: Pre-anuncio<\/li>\n<li>8 de enero de 2026: Lanzamiento<\/li>\n<li>10 de marzo de 2026: Fecha l\u00edmite para la pre-propuesta, 14:00 CET<\/li>\n<li>Finales de mayo de 2026: Invitaci\u00f3n formal para presentar la propuesta completa<\/li>\n<li>30 de junio de 2026: Fecha l\u00edmite de env\u00edo de propuestas completas, 14:00 CEST<\/li>\n<li>Septiembre de 2026: Reuni\u00f3n del Panel de Evaluaci\u00f3n para revisar las propuestas completas<\/li>\n<li>Noviembre de 2026: Decisi\u00f3n final de financiaci\u00f3n por el CSC e inicio de los procedimientos administrativos nacionales<\/li>\n<li>Principios \u2013 Mediados de 2027: Inicio esperado de la financiaci\u00f3n<\/li>\n<\/ul>\n<ul>\n<li style=\"list-style-type: none;\">\n<ul><\/ul>\n<\/li>\n<\/ul>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=\u00bb4.27.4&#8243; _module_preset=\u00bbdefault\u00bb width=\u00bb75.9%\u00bb custom_margin=\u00bb-50px|auto||159px|false|false\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_column type=\u00bb4_4&#8243; _builder_version=\u00bb4.25.1&#8243; _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_heading title=\u00bbDocumentaci\u00f3n y enlaces clave\u00bb _builder_version=\u00bb4.27.4&#8243; _module_preset=\u00bbdefault\u00bb title_font=\u00bb|||on|||||\u00bb title_text_color=\u00bb#0C71C3&#8243; min_height=\u00bb0px\u00bb custom_margin=\u00bb1px||||false|false\u00bb global_colors_info=\u00bb{}\u00bb custom_padding__hover_enabled=\u00bbon|desktop\u00bb][\/et_pb_heading][et_pb_text _builder_version=\u00bb4.27.4&#8243; _module_preset=\u00bbdefault\u00bb custom_padding=\u00bb||0px|11px||\u00bb link_option_url=\u00bbhttps:\/\/www.thcspartnership.eu\/funding\/jtc-2026-access-to-care.kl\u00bb global_colors_info=\u00bb{}\u00bb hover_enabled=\u00bb0&#8243; sticky_enabled=\u00bb0&#8243;]<\/p>\n<ul>\n<li style=\"list-style-type: none;\">\n<ul>\n<li style=\"list-style-type: none;\">\n<ul>\n<li data-start=\"6416\" data-end=\"6460\">\n<p data-start=\"6418\" data-end=\"6460\"><a data-start=\"6418\" data-end=\"6458\" class=\"decorated-link\" href=\"https:\/\/www.brainhealth-partnership.eu\/calls\/jtc2026-neurological-mental-sensory-disorders\/\">Web de la convocatoria<\/a><\/p>\n<\/li>\n<li data-start=\"6416\" data-end=\"6460\">\n<p data-start=\"6418\" data-end=\"6460\"><a data-start=\"6418\" data-end=\"6458\" class=\"decorated-link\" href=\"https:\/\/www.eppermed.eu\/funding-projects\/calls\/jtc2026\/\"><\/a><a href=\"https:\/\/www.brainhealth-partnership.eu\/wp-content\/uploads\/EPBrainHealth_CallText-JTC2026_1.pdf\">Texto de la convocatoria<\/a><\/p>\n<\/li>\n<li data-start=\"6416\" data-end=\"6460\">\n<p data-start=\"6418\" data-end=\"6460\"><a href=\"https:\/\/www.brainhealth-partnership.eu\/wp-content\/uploads\/NationalAnnexesCompiledCall-1.pdf\">Anexos Nacionales<\/a><\/p>\n<\/li>\n<li data-start=\"6416\" data-end=\"6460\">\n<p data-start=\"6418\" data-end=\"6460\"><a href=\"https:\/\/www.brainhealth-partnership.eu\/wp-content\/uploads\/NationalAnnexesCompiledCall-1.pdf\"><\/a><a href=\"https:\/\/ptoutline.eu\/app\/BrainHealth_PS\" style=\"font-size: 14px;\">Plataforma de env\u00edo de propuestas<\/a><\/p>\n<\/li>\n<li data-start=\"6416\" data-end=\"6460\">\n<p data-start=\"6418\" data-end=\"6460\"><a href=\"https:\/\/ptoutline.eu\/app\/EPPERMEDRITC2026\"><\/a><a href=\"https:\/\/www.brainhealth-partnership.eu\/wp-content\/uploads\/EPBrainHealth_Pre-proposal_template-JTC2026_1.docx\">Template de pre-propuesta<\/a><\/p>\n<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p>[\/et_pb_text][et_pb_heading title=\u00bbJTC2026 Call 2: Neurodegenerative Disorders\u00bb _builder_version=\u00bb4.27.4&#8243; _module_preset=\u00bbdefault\u00bb title_font=\u00bb|||on|||||\u00bb title_text_color=\u00bb#0C71C3&#8243; min_height=\u00bb0px\u00bb custom_margin=\u00bb20px||||false|false\u00bb hover_enabled=\u00bb0&#8243; global_colors_info=\u00bb{}\u00bb custom_padding__hover_enabled=\u00bbon|desktop\u00bb sticky_enabled=\u00bb0&#8243;][\/et_pb_heading][\/et_pb_column][\/et_pb_row][et_pb_row admin_label=\u00bbrow\u00bb _builder_version=\u00bb4.25.1&#8243; background_size=\u00bbinitial\u00bb background_position=\u00bbtop_left\u00bb background_repeat=\u00bbrepeat\u00bb width=\u00bb77.1%\u00bb custom_margin=\u00bb|-259px||161px||\u00bb custom_padding=\u00bb|0px||9px||\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_column type=\u00bb4_4&#8243; _builder_version=\u00bb4.16&#8243; custom_padding=\u00bb|||\u00bb global_colors_info=\u00bb{}\u00bb custom_padding__hover=\u00bb|||\u00bb][et_pb_text admin_label=\u00bbText\u00bb _builder_version=\u00bb4.27.4&#8243; header_text_color=\u00bb#000000&#8243; background_size=\u00bbinitial\u00bb background_position=\u00bbtop_left\u00bb background_repeat=\u00bbrepeat\u00bb width=\u00bb100%\u00bb custom_margin=\u00bb11px|-78px|||false|false\u00bb global_colors_info=\u00bb{}\u00bb hover_enabled=\u00bb0&#8243; sticky_enabled=\u00bb0&#8243;]<\/p>\n<p data-start=\"278\" data-end=\"709\">La convocatoria JTC2026 Call 2 de BrainHealth se centra en los factores biol\u00f3gicos, sociales y ambientales que influyen en la salud cerebral a lo largo de la vida, en el \u00e1mbito de los trastornos neurodegenerativos. El objetivo es promover investigaciones multinacionales, colaborativas e interdisciplinarias que aborden preguntas cr\u00edticas de car\u00e1cter translacional sobre la trayectoria de la salud cerebral.<\/p>\n<p data-start=\"1190\" data-end=\"1383\">Los proyectos deben ser interdisciplinarios y abordar al menos dos de los tres factores que impactan la trayectoria de la salud cerebral en el \u00e1mbito de los trastornos neurodegenerativos:<\/p>\n<ul data-start=\"1385\" data-end=\"2124\">\n<li data-start=\"1385\" data-end=\"1593\">\n<p data-start=\"1387\" data-end=\"1593\">Factores biol\u00f3gicos, por ejemplo: gen\u00e9tica, epigen\u00e9tica, \u00f3micas, neuroplasticidad, inflamaci\u00f3n, infecci\u00f3n, sinaptog\u00e9nesis, circuitos neuronales, factores vasculares, d\u00e9ficit sensorial, comorbilidades.<\/p>\n<\/li>\n<li data-start=\"1594\" data-end=\"1938\">\n<p data-start=\"1596\" data-end=\"1938\">Factores de estilo de vida y sociales, por ejemplo: ejercicio\/actividad f\u00edsica, nutrici\u00f3n, sue\u00f1o, consumo de tabaco, alcohol o drogas, trabajo (ingresos, empleo), contexto socioecon\u00f3mico, raza\/etnia, sexo y g\u00e9nero, educaci\u00f3n, seguridad, interacciones sociales (familia\/amigos), acceso a la atenci\u00f3n sanitaria, estr\u00e9s, trauma, migraci\u00f3n.<\/p>\n<\/li>\n<li data-start=\"1939\" data-end=\"2124\">\n<p data-start=\"1941\" data-end=\"2124\">Factores ambientales, por ejemplo: contaminaci\u00f3n\/contaminantes, urbanizaci\u00f3n, desastres, pandemias, conflictos b\u00e9licos, cambio clim\u00e1tico, microbiota, contacto con la naturaleza.<\/p>\n<\/li>\n<\/ul>\n<p data-start=\"2126\" data-end=\"2213\">Adem\u00e1s, las solicitudes deben investigar al menos dos de los siguientes aspectos:<\/p>\n<ul data-start=\"2215\" data-end=\"2492\">\n<li data-start=\"2215\" data-end=\"2270\">\n<p data-start=\"2217\" data-end=\"2270\">Mecanismos de acci\u00f3n de los factores identificados.<\/p>\n<\/li>\n<li data-start=\"2271\" data-end=\"2364\">\n<p data-start=\"2273\" data-end=\"2364\">Reconocimiento temprano, diagn\u00f3stico y pron\u00f3stico asociados a los factores identificados.<\/p>\n<\/li>\n<li data-start=\"2365\" data-end=\"2492\">\n<p data-start=\"2367\" data-end=\"2492\">Prevenci\u00f3n, tratamientos, intervenciones, desarrollo tecnol\u00f3gico, atenci\u00f3n y apoyo vinculados a los factores identificados.<\/p>\n<\/li>\n<\/ul>\n<p data-start=\"2494\" data-end=\"2580\">Adem\u00e1s, los siguientes aspectos son importantes en el contexto de esta convocatoria:<\/p>\n<ul data-start=\"2582\" data-end=\"3244\">\n<li data-start=\"2582\" data-end=\"2704\">\n<p data-start=\"2584\" data-end=\"2704\">Las solicitudes deben investigar c\u00f3mo los factores impactan la trayectoria de la salud cerebral a lo largo de la vida.<\/p>\n<\/li>\n<li data-start=\"2705\" data-end=\"2878\">\n<p data-start=\"2707\" data-end=\"2878\">Los resultados que beneficien la calidad de vida de los pacientes y sus cuidadores son de especial importancia y deben ser definidos y especificados de manera expl\u00edcita.<\/p>\n<\/li>\n<li data-start=\"2879\" data-end=\"3012\">\n<p data-start=\"2881\" data-end=\"3012\">Se fomentan las propuestas que aborden aspectos relacionados con discapacidad, g\u00e9nero, \u00e9tica, cultura y factores socioecon\u00f3micos.<\/p>\n<\/li>\n<li data-start=\"3013\" data-end=\"3244\">\n<p data-start=\"3015\" data-end=\"3244\">Se valorar\u00e1n especialmente los enfoques que integren datos multimodales, el uso de tecnolog\u00edas port\u00e1tiles accesibles (por ejemplo, dispositivos m\u00f3viles), inteligencia artificial\/gemelos digitales y la reutilizaci\u00f3n de f\u00e1rmacos.<\/p>\n<\/li>\n<\/ul>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=\u00bb4.27.4&#8243; _module_preset=\u00bbdefault\u00bb width=\u00bb75.9%\u00bb custom_margin=\u00bb14px|auto|-13px|159px|false|false\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_column type=\u00bb4_4&#8243; _builder_version=\u00bb4.25.1&#8243; _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_heading title=\u00bbCondiciones generales\u00bb _builder_version=\u00bb4.27.4&#8243; _module_preset=\u00bbdefault\u00bb title_font=\u00bb|||on|||||\u00bb title_text_color=\u00bb#0C71C3&#8243; min_height=\u00bb0px\u00bb custom_margin=\u00bb1px||||false|false\u00bb global_colors_info=\u00bb{}\u00bb custom_padding__hover_enabled=\u00bbon|desktop\u00bb][\/et_pb_heading][et_pb_text _builder_version=\u00bb4.27.4&#8243; _module_preset=\u00bbdefault\u00bb custom_padding=\u00bb||0px|11px||\u00bb global_colors_info=\u00bb{}\u00bb]<\/p>\n<ul>\n<li>Pa\u00edses participantes: Australia, Austria, B\u00e9lgica (Federaci\u00f3n Valona-Bruselas), B\u00e9lgica (Flandes), Canad\u00e1, Croacia, Dinamarca, Estonia, Finlandia, Francia, Alemania, Grecia, Hungr\u00eda, Irlanda, Islandia, Israel, Italia, Italia (Regi\u00f3n de Lombard\u00eda), Letonia, Lituania, Luxemburgo, Malta, Pa\u00edses Bajos, Noruega, Polonia, Portugal, Rep\u00fablica de Moldavia, Ruman\u00eda, Eslovaquia, Eslovenia, Espa\u00f1a, Suecia, Taiw\u00e1n y Turqu\u00eda..<\/li>\n<li>Cada socio del proyecto ser\u00e1 financiado por su organismo nacional\/regional correspondiente.<\/li>\n<li>El consorcio m\u00ednimo elegible ser\u00e1 de socios elegibles de 3 pa\u00edses diferentes participantes en la convocatoria.<\/li>\n<li>El consorcio m\u00e1ximo ser\u00e1 de 6 socios financiables, con un m\u00e1ximo de 2 socios elegibles por pa\u00eds.\u00a0<\/li>\n<li>Si en el consorcio Croacia, Malta, Moldavia, Eslovaquia, Eslovenia, Turqu\u00eda.<\/li>\n<li>Se permiten colaboradores autofinanciados, que se contabilizar\u00e1n en el consorcio de la misma manera que los socios.<\/li>\n<li>Procedimiento en <strong data-start=\"2896\" data-end=\"2910\">dos fases:<\/strong> pre-propuestas y propuestas completas.<\/li>\n<\/ul>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=\u00bb4.27.4&#8243; _module_preset=\u00bbdefault\u00bb width=\u00bb75.9%\u00bb custom_margin=\u00bb14px|auto|-13px|159px|false|false\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_column type=\u00bb4_4&#8243; _builder_version=\u00bb4.25.1&#8243; _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_heading title=\u00bbFinanciaci\u00f3n\u00bb _builder_version=\u00bb4.27.4&#8243; _module_preset=\u00bbdefault\u00bb title_font=\u00bb|||on|||||\u00bb title_text_color=\u00bb#0C71C3&#8243; min_height=\u00bb0px\u00bb custom_margin=\u00bb1px||||false|false\u00bb global_colors_info=\u00bb{}\u00bb custom_padding__hover_enabled=\u00bbon|desktop\u00bb][\/et_pb_heading][et_pb_text _builder_version=\u00bb4.27.4&#8243; _module_preset=\u00bbdefault\u00bb custom_padding=\u00bb||0px|11px||\u00bb global_colors_info=\u00bb{}\u00bb]<\/p>\n<p><strong data-start=\"465\" data-end=\"531\" style=\"font-size: 14px;\">Las entidades espa\u00f1olas podr\u00e1n solicitar los fondos al Instituto de Salud Carlos III, con las siguientes reglas:<\/strong><\/p>\n<ul data-start=\"534\" data-end=\"944\">\n<li data-start=\"534\" data-end=\"758\">\n<p data-start=\"536\" data-end=\"559\">Como <strong data-start=\"541\" data-end=\"556\">coordinador<\/strong>:<\/p>\n<ul data-start=\"562\" data-end=\"758\">\n<li data-start=\"562\" data-end=\"639\">\n<p data-start=\"564\" data-end=\"639\"><strong data-start=\"564\" data-end=\"577\">275.000 \u20ac<\/strong>, si hay solo un socio espa\u00f1ol solicitando fondos al ISCIII.<\/p>\n<\/li>\n<li data-start=\"642\" data-end=\"758\">\n<p data-start=\"644\" data-end=\"758\"><strong data-start=\"644\" data-end=\"668\">300.000 \u20ac a repartir<\/strong>, si hay dos socios solicitando financiaci\u00f3n al ISCIII, siendo uno de ellos coordinador.<\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li data-start=\"759\" data-end=\"944\">\n<p data-start=\"761\" data-end=\"778\">Como <strong data-start=\"766\" data-end=\"775\">socio<\/strong>:<\/p>\n<ul data-start=\"781\" data-end=\"944\">\n<li data-start=\"781\" data-end=\"858\">\n<p data-start=\"783\" data-end=\"858\"><strong data-start=\"783\" data-end=\"796\">220.000 \u20ac<\/strong>, si hay solo un socio espa\u00f1ol solicitando fondos al ISCIII.<\/p>\n<\/li>\n<li data-start=\"861\" data-end=\"944\">\n<p data-start=\"863\" data-end=\"944\"><strong data-start=\"863\" data-end=\"887\">250.000 \u20ac a repartir<\/strong>, si hay dos socios solicitando financiaci\u00f3n al ISCIII.<\/p>\n<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=\u00bb4.27.4&#8243; _module_preset=\u00bbdefault\u00bb width=\u00bb75.9%\u00bb min_height=\u00bb317px\u00bb custom_margin=\u00bb10px|auto||159px|false|false\u00bb custom_padding=\u00bb||0px|||\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_column type=\u00bb4_4&#8243; _builder_version=\u00bb4.25.1&#8243; _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_heading title=\u00bbfechas clave\u00bb _builder_version=\u00bb4.27.4&#8243; _module_preset=\u00bbdefault\u00bb title_font=\u00bb|||on|||||\u00bb title_text_color=\u00bb#0C71C3&#8243; min_height=\u00bb0px\u00bb custom_margin=\u00bb1px||||false|false\u00bb global_colors_info=\u00bb{}\u00bb custom_padding__hover_enabled=\u00bbon|desktop\u00bb][\/et_pb_heading][et_pb_text _builder_version=\u00bb4.27.4&#8243; _module_preset=\u00bbdefault\u00bb custom_margin=\u00bb||8px|||\u00bb custom_padding=\u00bb||0px|11px||\u00bb global_colors_info=\u00bb{}\u00bb]<\/p>\n<ul>\n<li>8 de diciembre de 2025: Pre-anuncio<\/li>\n<li>8 de enero de 2026: Lanzamiento<\/li>\n<li>10 de marzo de 2026: Fecha l\u00edmite para la pre-propuesta, 14:00 CET<\/li>\n<li>Finales de mayo de 2026: Invitaci\u00f3n formal para presentar la propuesta completa<\/li>\n<li>30 de junio de 2026: Fecha l\u00edmite de env\u00edo de propuestas completas, 14:00 CEST<\/li>\n<li>Septiembre de 2026: Reuni\u00f3n del Panel de Evaluaci\u00f3n para revisar las propuestas completas<\/li>\n<li>Noviembre de 2026: Decisi\u00f3n final de financiaci\u00f3n por el CSC e inicio de los procedimientos administrativos nacionales<\/li>\n<li>Principios \u2013 Mediados de 2027: Inicio esperado de la financiaci\u00f3n<\/li>\n<\/ul>\n<ul>\n<li style=\"list-style-type: none;\">\n<ul><\/ul>\n<\/li>\n<\/ul>\n<p>[\/et_pb_text][et_pb_heading title=\u00bbDocumentaci\u00f3n y enlaces clave\u00bb _builder_version=\u00bb4.27.4&#8243; _module_preset=\u00bbdefault\u00bb title_font=\u00bb|||on|||||\u00bb title_text_color=\u00bb#0C71C3&#8243; min_height=\u00bb0px\u00bb custom_margin=\u00bb-21px||||false|false\u00bb global_colors_info=\u00bb{}\u00bb custom_padding__hover_enabled=\u00bbon|desktop\u00bb hover_enabled=\u00bb0&#8243; sticky_enabled=\u00bb0&#8243;][\/et_pb_heading][et_pb_text _builder_version=\u00bb4.27.4&#8243; _module_preset=\u00bbdefault\u00bb custom_padding=\u00bb||0px|11px||\u00bb link_option_url=\u00bbhttps:\/\/www.thcspartnership.eu\/funding\/jtc-2026-access-to-care.kl\u00bb global_colors_info=\u00bb{}\u00bb hover_enabled=\u00bb0&#8243; sticky_enabled=\u00bb0&#8243;]<\/p>\n<ul>\n<li style=\"list-style-type: none;\">\n<ul>\n<li style=\"list-style-type: none;\">\n<ul>\n<li data-start=\"6416\" data-end=\"6460\">\n<p data-start=\"6418\" data-end=\"6460\"><a data-start=\"6418\" data-end=\"6458\" class=\"decorated-link\" href=\"https:\/\/www.brainhealth-partnership.eu\/calls\/jtc2026-neurodegenerative-disorders\/\">Web de la convocatoria<\/a><\/p>\n<\/li>\n<li data-start=\"6416\" data-end=\"6460\">\n<p data-start=\"6418\" data-end=\"6460\"><a data-start=\"6418\" data-end=\"6458\" class=\"decorated-link\" href=\"https:\/\/www.eppermed.eu\/funding-projects\/calls\/jtc2026\/\"><\/a><a href=\"https:\/\/www.brainhealth-partnership.eu\/wp-content\/uploads\/EPBrainHealth_CallText-JTC2026_2.pdf\">Texto de la convocatoria<\/a><\/p>\n<\/li>\n<li data-start=\"6416\" data-end=\"6460\">\n<p data-start=\"6418\" data-end=\"6460\"><a href=\"https:\/\/www.brainhealth-partnership.eu\/wp-content\/uploads\/EPBrainHealth_CallText-JTC2026_2.pdf\">Anexos Nacionales<\/a><\/p>\n<\/li>\n<li data-start=\"6416\" data-end=\"6460\">\n<p data-start=\"6418\" data-end=\"6460\"><a href=\"https:\/\/www.brainhealth-partnership.eu\/wp-content\/uploads\/NationalAnnexesCompiledCall-1.pdf\"><\/a><a href=\"https:\/\/www.brainhealth-partnership.eu\/wp-content\/uploads\/EPBrainHealth_Pre-proposal_template-JTC2026_2.docx\">Plataforma de env\u00edo de propuestas<\/a><\/p>\n<\/li>\n<li data-start=\"6416\" data-end=\"6460\">\n<p data-start=\"6418\" data-end=\"6460\"><a href=\"https:\/\/ptoutline.eu\/app\/EPPERMEDRITC2026\"><\/a><a href=\"https:\/\/ptoutline.eu\/app\/BrainHealth_ND\">Template de pre-propuesta<\/a><\/p>\n<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>El partneriado BrainHealth Partnership ha lanzado dos convocatorias en el a\u00f1o soso6, siendo estas: JTC2026 Call 1: Neurological Mental and Sensory Disorders JTC2026 Call 2: Neurodegenerative Disorders La convocatoria JTC2026 Call 1 de BrainHealth se centra en los factores biol\u00f3gicos, sociales y ambientales que influyen en la salud cerebral a lo largo de la vida, [&hellip;]<\/p>\n","protected":false},"author":4,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"_et_pb_use_builder":"on","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"class_list":["post-59613","page","type-page","status-publish","hentry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Brain Health PARTNERSHIP - Ibima<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ibima.eu\/en\/brain-health-partnership\/\" \/>\n<meta property=\"og:locale\" content=\"en_GB\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Brain Health PARTNERSHIP - Ibima\" \/>\n<meta property=\"og:description\" content=\"El partneriado BrainHealth Partnership ha lanzado dos convocatorias en el a\u00f1o soso6, siendo estas: JTC2026 Call 1: Neurological Mental and Sensory Disorders JTC2026 Call 2: Neurodegenerative Disorders La convocatoria JTC2026 Call 1 de BrainHealth se centra en los factores biol\u00f3gicos, sociales y ambientales que influyen en la salud cerebral a lo largo de la vida, [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ibima.eu\/en\/brain-health-partnership\/\" \/>\n<meta property=\"og:site_name\" content=\"Ibima\" \/>\n<meta property=\"article:modified_time\" content=\"2026-01-19T07:29:34+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Estimated reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/ibima.eu\\\/es\\\/brain-health-partnership\\\/\",\"url\":\"https:\\\/\\\/ibima.eu\\\/es\\\/brain-health-partnership\\\/\",\"name\":\"Brain Health PARTNERSHIP - Ibima\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ibima.eu\\\/es\\\/#website\"},\"datePublished\":\"2026-01-18T18:19:07+00:00\",\"dateModified\":\"2026-01-19T07:29:34+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/ibima.eu\\\/es\\\/brain-health-partnership\\\/#breadcrumb\"},\"inLanguage\":\"en-GB\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/ibima.eu\\\/es\\\/brain-health-partnership\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/ibima.eu\\\/es\\\/brain-health-partnership\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Portada\",\"item\":\"https:\\\/\\\/ibima.eu\\\/es\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Brain Health PARTNERSHIP\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/ibima.eu\\\/es\\\/#website\",\"url\":\"https:\\\/\\\/ibima.eu\\\/es\\\/\",\"name\":\"Ibima\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/ibima.eu\\\/es\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-GB\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Brain Health PARTNERSHIP - Ibima","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ibima.eu\/en\/brain-health-partnership\/","og_locale":"en_GB","og_type":"article","og_title":"Brain Health PARTNERSHIP - Ibima","og_description":"El partneriado BrainHealth Partnership ha lanzado dos convocatorias en el a\u00f1o soso6, siendo estas: JTC2026 Call 1: Neurological Mental and Sensory Disorders JTC2026 Call 2: Neurodegenerative Disorders La convocatoria JTC2026 Call 1 de BrainHealth se centra en los factores biol\u00f3gicos, sociales y ambientales que influyen en la salud cerebral a lo largo de la vida, [&hellip;]","og_url":"https:\/\/ibima.eu\/en\/brain-health-partnership\/","og_site_name":"Ibima","article_modified_time":"2026-01-19T07:29:34+00:00","twitter_card":"summary_large_image","twitter_misc":{"Estimated reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/ibima.eu\/es\/brain-health-partnership\/","url":"https:\/\/ibima.eu\/es\/brain-health-partnership\/","name":"Brain Health PARTNERSHIP - Ibima","isPartOf":{"@id":"https:\/\/ibima.eu\/es\/#website"},"datePublished":"2026-01-18T18:19:07+00:00","dateModified":"2026-01-19T07:29:34+00:00","breadcrumb":{"@id":"https:\/\/ibima.eu\/es\/brain-health-partnership\/#breadcrumb"},"inLanguage":"en-GB","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ibima.eu\/es\/brain-health-partnership\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/ibima.eu\/es\/brain-health-partnership\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Portada","item":"https:\/\/ibima.eu\/es\/"},{"@type":"ListItem","position":2,"name":"Brain Health PARTNERSHIP"}]},{"@type":"WebSite","@id":"https:\/\/ibima.eu\/es\/#website","url":"https:\/\/ibima.eu\/es\/","name":"Ibima","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ibima.eu\/es\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-GB"}]}},"_links":{"self":[{"href":"https:\/\/ibima.eu\/en\/wp-json\/wp\/v2\/pages\/59613","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ibima.eu\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/ibima.eu\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/ibima.eu\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/ibima.eu\/en\/wp-json\/wp\/v2\/comments?post=59613"}],"version-history":[{"count":4,"href":"https:\/\/ibima.eu\/en\/wp-json\/wp\/v2\/pages\/59613\/revisions"}],"predecessor-version":[{"id":59621,"href":"https:\/\/ibima.eu\/en\/wp-json\/wp\/v2\/pages\/59613\/revisions\/59621"}],"wp:attachment":[{"href":"https:\/\/ibima.eu\/en\/wp-json\/wp\/v2\/media?parent=59613"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}